Related Experiment Video
Updated: Jul 10, 2026

An Improved Method to Isolate Mitochondrial Contact Sites
Published on: June 16, 2023
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal
Julie van der Zee1, Hazel Urwin, Sebastiaan Engelborghs
1Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium.
Abstract:
The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3). In this family, a mutation in the acceptor splice site of exon 6 produced two aberrant transcripts predicting two C-truncated CHMP2B proteins due to a read through of intron 5 (p.Met178ValfsX2) and a cryptic splicing event within exon 6 (p.Met178LeufsX30). Extensive mutation analysis of CHMP2B in Belgian patients (N = 146) identified one nonsense mutation in exon 5 (c.493C>T) in a familial FTLD patient, predicting a C-truncated protein p.Gln165X analogous to the Danish mutant proteins. Overexpression of Belgian p.Gln165X in human neuroblastoma SK-N-SH cells showed the formation of large, aberrant endosomal structures that were highly similar to those observed for Danish p.Met178ValfsX2. Together, these data suggest that C-truncating mutations in CHMP2B might underlie the pathogenic mechanism in FTLD by disturbing endosome function. We also describe a missense mutation in exon 5 of CHMP2B (p.Asn143Ser) in a familial patient with cortical basal degeneration. However, the pathogenic character of this mutation remains elusive.
Insights
C-truncating mutations in the charged multivesicular body protein 2B gene (CHMP2B) are linked to frontotemporal lobar degeneration (FTLD). These mutations disrupt endosome function, suggesting a pathogenic mechanism for FTLD.
Area of Science:
- Genetics
- Neuroscience
- Cell Biology
Background:
- The charged multivesicular body protein 2B (CHMP2B) gene has been linked to frontotemporal lobar degeneration (FTLD).
- A Danish FTLD family (FTD-3) exhibited mutations in CHMP2B, leading to C-truncated proteins and aberrant endosomal structures.
Purpose of the Study:
- To investigate the role of CHMP2B mutations in frontotemporal lobar degeneration (FTLD).
- To analyze CHMP2B mutation carriers in Belgian FTLD patients and characterize the functional impact of identified mutations.
Main Methods:
- Mutation analysis of the CHMP2B gene in 146 Belgian FTLD patients.
- In vitro overexpression of a novel CHMP2B mutant protein (p.Gln165X) in human neuroblastoma SK-N-SH cells.
- Microscopic analysis of endosomal structures in cells expressing mutant CHMP2B.
Main Results:
- A nonsense mutation (c.493C>T) in CHMP2B exon 5 was identified in a familial FTLD patient, predicting a C-truncated protein (p.Gln165X).
- Overexpression of p.Gln165X induced large, aberrant endosomal structures similar to those caused by Danish CHMP2B mutants.
- A missense mutation (p.Asn143Ser) was found in a familial patient with cortical basal degeneration, but its pathogenicity is undetermined.
Conclusions:
- C-truncating CHMP2B mutations may cause FTLD by disrupting endosome function.
- The findings support CHMP2B as a potential FTLD-associated gene.
- Further research is needed to elucidate the pathogenicity of the identified missense mutation.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Lysosomal Hydrolases
Huntington Disease l: Introduction